We tested the effect of Slit3 repression on the response of HCC cell lines to sorafenib, an oral multikinase inhibitor that executes its antitumor activities by blocking tumor angiogenesis, targeting the Raf/Mek/Erk pathway and inducing cell apoptosis [8]. The gene discussed is SLIT3; the disease is hepatocellular carcinoma.